Parris Toshima Z相关文献与解析，生知库 | 链接生命科学的每一步

Ittner, Ella; Werner, Lucas; Swenson, Hugo; Linder, Anna; Sundfeldt, Karin; Saed, Ghassan; Karlsson, Per; Parris, Toshima Z; Kovács, Anikó; Helou, Khalil

信号转导

肿瘤

肿瘤免疫

发表日期：2026

文献求助收藏

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity

卵巢癌蛋白质组学分析揭示了具有组织学类型和分期特异性的诊断和预后生物标志物

期刊:Journal of Ovarian Research

影响因子:4.2

doi:10.1186/s13048-026-01984-4

Werner, Lucas; Ittner, Ella; Swenson, Hugo; Rönnerman, Elisabeth Werner; Mateoiu, Claudia; Kovács, Anikó; Dahm-Kähler, Pernilla; Karlsson, Per; Parris, Toshima Z; Helou, Khalil

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response

不同种族人群乳腺癌中免疫基质异质性：对预后和治疗反应的影响

期刊:NPJ Breast Cancer

影响因子:7.6

doi:10.1038/s41523-025-00881-1

Alamukii, Nanfizat A; Kovács, Anikó; Raghavan, Sukanya; Ilio, Josefin; Karlsson, Per; Helou, Khalil; Parris, Toshima Z

Attenuated titin protein expression is associated with advanced stages of ovarian cancer

肌联蛋白表达减弱与卵巢癌晚期相关

期刊:Molecular Therapy Oncology

影响因子:5.3

doi:10.1016/j.omton.2025.200932

Sharma, Harvey; Aujla, Jaskaran; Nawaz, Asad; Khasawneh, Thabet; Alvero, Ayesha; Morris, Robert T; Basha, Asma; Tutunji, Laila; Parris, Toshima Z; Helou, Khalil; Saed, Ghassan M

Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics

利用蛋白质组学揭示卵巢癌组织类型特异性生物标志物

期刊:Molecular Therapy Oncology

影响因子:5.3

doi:10.1016/j.omton.2025.201019

Werner, Lucas; Ittner, Ella; Swenson, Hugo; Rönnerman, Elisabeth Werner; Mateoiu, Claudia; Kovács, Anikó; Dahm-Kähler, Pernilla; Karlsson, Per; Thorsell, Annika; Rekabdar, Elham; Esmaeili, Parisa; Levander, Fredrik; Forssell-Aronsson, Eva; Tullberg, Axel Stenmark; Saed, Ghassan; Parris, Toshima Z; Helou, Khalil

Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma

表观遗传和转录相互关系的整合分析可识别早期卵巢癌的组织类型特异性生物标志物

期刊:Journal of Ovarian Research

影响因子:4.2

doi:10.1186/s13048-025-01676-5

Swenson, Hugo; Ittner, Ella; Werner, Lucas; Rönnerman, Elisabeth Werner; Mateoiu, Claudia; Kovács, Anikó; Dahm-Kähler, Pernilla; Saed, Ghassan M; Nemes, Szilárd; Karlsson, Per; Parris, Toshima Z; Helou, Khalil

Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancer.

新的基因重排导致敏感型和耐药型卵巢癌中 Hornerin 的表达发生改变

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2025.102495

Saed Ghassan M, Sharma Harvey, Dabaja Jenna, Nawaz Asad, Alvero Ayesha, Morris Robert T, Basha Asma, Werner Lucas, Parris Toshima Z, Helou Khalil

Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer

晚期上皮性卵巢癌组织学类型相关的诊断和预后生物标志物

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-24938-0

Ittner, Ella; Swenson, Hugo; Werner, Lucas; Rönnerman, Elisabeth Werner; Mateoiu, Constantina; Kovács, Anikó; Dahm-Kähler, Pernilla; Saed, Ghassan; Karlsson, Per; Parris, Toshima Z; Helou, Khalil

The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study

新辅助化疗后Ki67变化对残留三阴性乳腺癌预后价值的预测：一项基于瑞典全国登记数据的研究

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-025-07610-z

Nyqvist-Streng, Jenny; Helou, Mikael; Helou, Khalil; Chamalidou, Chaido; Kovács, Anikó; Parris, Toshima Z

Correction: Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence

更正：通过常规光学显微镜、数字病理学和人工智能评估 47 例晚期乳腺癌核心活检、匹配的手术标本及其远处转移灶中 HER2low 和 HER2-ultralow 状态的变化

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-025-07828-x

Kovács, Anikó; Klint, Leif; Linderholm, Barbro; Parris, Toshima Z

LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis

LMTK3作为上皮性卵巢肿瘤发生过程中空间调控和阶段依赖性生物标志物

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity

卵巢癌蛋白质组学分析揭示了具有组织学类型和分期特异性的诊断和预后生物标志物

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response

不同种族人群乳腺癌中免疫基质异质性：对预后和治疗反应的影响

Attenuated titin protein expression is associated with advanced stages of ovarian cancer

肌联蛋白表达减弱与卵巢癌晚期相关

Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics

利用蛋白质组学揭示卵巢癌组织类型特异性生物标志物

Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma

表观遗传和转录相互关系的整合分析可识别早期卵巢癌的组织类型特异性生物标志物

Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancer.

新的基因重排导致敏感型和耐药型卵巢癌中 Hornerin 的表达发生改变

Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer

晚期上皮性卵巢癌组织学类型相关的诊断和预后生物标志物

The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study

新辅助化疗后Ki67变化对残留三阴性乳腺癌预后价值的预测：一项基于瑞典全国登记数据的研究

Correction: Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence

更正：通过常规光学显微镜、数字病理学和人工智能评估 47 例晚期乳腺癌核心活检、匹配的手术标本及其远处转移灶中 HER2low 和 HER2-ultralow 状态的变化